Related Experiment Video
Updated: Mar 10, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Indications For AF Ablation: Before Or After The Failure Of Antiarrhythmic Drug Therapy?
Akira Kimata1, Yoko Ito1, Kentaro Yoshida1
1Division of Cardiovascular Medicine, Ibaraki Prefectural Central Hospital, Kasama, Japan.
Insights
Catheter ablation for atrial fibrillation (AF) offers benefits but antiarrhythmic drugs remain first-line for most patients due to ablation risks. Experience and center volume impact complication rates.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Atrial fibrillation (AF) management strategies are evolving.
- Catheter ablation is increasingly common but carries risks.
Approach:
- Review of current evidence on AF treatments.
- Analysis of ablation risks versus benefits.
Key Points:
- Catheter ablation is effective for maintaining sinus rhythm in AF.
- Antiarrhythmic drugs are recommended first-line for most AF patients.
- Younger patients with symptomatic paroxysmal AF without structural heart disease may benefit from ablation.
- Center volume and operator experience significantly influence complication rates.
- Ablation may prevent atrial remodeling and progression to persistent AF.
Conclusions:
- Current guidelines support antiarrhythmic drugs as first-line therapy for most AF patients.
- Further long-term data is required to assess ablation's impact on prognosis and remodeling.
- Careful patient selection and consideration of procedural risks are crucial.
Abstract:
Catheter ablation of atrial fibrillation (AF) is considered to be better than anti-arrhythmic drug therapy in terms of maintaining sinus rhythm, and therefore, it has rapidly evolved to become a commonly performed procedure in major hospitals throughout the world. However, on the basis of the evidence currently available, we support the current guidelines recommending antiarrhythmic drugs as a first-line treatment in most patients with AF except younger patients with symptomatic paroxysmal AF with no evidence of structural heart disease, given the risk of fatal complications associated with the ablation procedure. We would like to emphasize that center volume and individual procedure experience are significant determinants of procedure-related complications. As another effect of AF ablation, preventing atrial remodeling and progression to persistent AF is also noteworthy. Further long-term data is needed to answer the question of whether ablation can prevent or delay the advance of structural remodeling and improve life prognosis, particularly in younger patients.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management

